| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From Clemson University (J.A.M., F.S.S., C.G., W.V.G.), Clemson, SC; and Adrian College, Adrian, MI (S.G.H.).
Address correspondence and reprint requests to James A. McCubbin, PhD, Department of Psychology, Clemson University, 418 Brackett Hall, Clemson, SC 29634-1355. E-mail: jmccubb{at}clemson.edu
Objective: Acute pain sensitivity is reduced in clinical hypertension, but the precise relationship between pain perception and altered blood pressure control is not well-characterized. A negative correlation between resting blood pressure and pain sensitivity is observed throughout the normotensive range, suggesting links between basic mechanisms of blood pressure control and pain regulation. The opioid peptides are important endogenous analgesic mechanisms, but their role in the hypoalgesia of blood pressure elevations has not been well-established. The current study sought to examine the effects of endogenous opioids on blood pressure-associated hypoalgesia in young adults at risk for hypertension development.
Methods: The effects of the opioid receptor antagonist, naltrexone, on cold pressor pain sensitivity were assessed in young adult men (n = 49) and women (n = 76) with mildly elevated casual blood pressure.
Results: Results indicate interactions between hypertension risk and the effects of opioid blockade on pain sensitivity.
Conclusions: These findings suggest exaggerated opioid analgesia in persons at enhanced risk for hypertension and point to important links between altered neuropeptide regulation of pain and altered blood pressure control mechanisms in the early stages of hypertension.
Key Words: opioids pain analgesia blood pressure hypertension risk
Abbreviations: HR = heart rate; SBP = systolic blood pressure; DBP = diastolic blood pressure; MAP = mean arterial pressure; HPA = hypothalamic pituitary adrenocortical; CRF = corticotropin-releasing factor.
This article has been cited by other articles:
![]() |
J. W. Younger, K. A. Lawler-Row, K. A. Moe, A. L. Kratz, and A. J. Keenum Effects of naltrexone on repressive coping and disclosure of emotional material: a test of the opioid-Peptide hypothesis of repression and hypertension. Psychosom Med, September 1, 2006; 68(5): 734 - 741. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |